Search - tctmd.com

Displaying 21 - 40 of 71

Sort: Relevancy | Date

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Shelley Wood

March 02, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

Advertisement

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

TCTMD’s Top 10 Most Popular Stories for October 2021

TCTMD’s Top 10 Most Popular Stories for September 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

July/August 2021 News Roundup

Making the Case for Sex-Specific CVD Guidelines

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

TCTMD’s Top 10 Most Popular Stories for May 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Pneumonia in HF Patients Is Common, Lethal, and Preventable

TCTMD’s Top 10 Most Popular Stories for February 2021

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

December 2020 News Roundup

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

TCTMD’s Top 10 Most Popular Stories for September 2020

August 2020 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content